%PDF-1.7 %âãÏÓ 8 0 obj > endobj xref 8 100 0000000016 00000 n 0000002644 00000 n 0000002767 00000 n 0000003943 00000 n 0000004101 00000 n 0000004234 00000 n 0000004368 00000 n 0000004502 00000 n 0000004636 00000 n 0000004769 00000 n 0000004903 00000 n 0000005036 00000 n 0000005170 00000 n 0000005303 00000 n 0000005436 00000 n 0000005570 00000 n 0000005704 00000 n 0000005838 00000 n ...

This section includes selected Pfizer abstracts, posters or oral presentations, which have been accepted for congress presentations in the last 2 years. The content contained in this section is subject to congress copyright permissions.

Pfizer's Sponsored Scientific Presentations including Abstract Plain Language Summaries. The Role of Cyclin-Dependent Kinases (CDK) 2/4/6 in Normal and Tumor Cells. Exploring Alternative Targets in Hemophilia- Revisiting Tissue Factor Pathway Inhibitor. Pfizer Gene Therapy. Pfizer’s Leadership Through Science: Driving Innovation in Hematology ...

Mar 3, 2025 · This webcast may contain forward-looking statements about, among other things, our anticipated operating and financial performance, reorganizations, business plans and prospects; expectations for our product pipeline, in-line products and product candidates, including anticipated regulatory submissions, data read-outs, study starts, approvals ...

Visit our site to browse available HCP or patient education materials including posters, brochures & guides for a therapy area or product.

%PDF-1.4 %âãÏÓ 254 0 obj > endobj xref 254 79 0000000016 00000 n 0000002383 00000 n 0000002539 00000 n 0000006237 00000 n 0000006368 00000 n 0000006522 00000 n 0000006666 00000 n 0000006810 00000 n 0000006954 00000 n 0000007098 00000 n 0000007242 00000 n 0000007386 00000 n 0000007520 00000 n 0000007651 00000 n 0000007782 00000 n 0000007913 00000 n 0000008047 00000 n 0000008178 00000 n ...

This section includes selected Pfizer abstracts, posters or oral presentations, which have been accepted for congresses presentation in the last 2 years. Information in this section may include on-label, off-label dosing, Pfizer-sponsored-RWE and pipeline products. The content contained in this section is subject to congress copyright permissions.

Mohty M et al. Poster presentation at EHA 2024 (Abstract P932). Long-Term Survival After Elranatamab Monotherapy in Patients With Relapsed or Refractory Multiple Myeloma: MagnetisMM-3

All pfizer posters are produced on-demand using archival inks, ship within 48 hours, and include a 30-day money-back guarantee. Customize your pfizer poster with hundreds of different frame options, and get the exact look that you want for your wall!

May 19, 2023 · Pfizer Oncology Sponsored Abstracts . 2023 American Society of Clinical Oncology (ASCO) Annual Meeting . Last Updated: May 19, 2023 . The majority of Annual Meeting abstracts will be released at 5:00 PM ET on Thursday, May 25, 2023. Late-Breaking Abstracts (LBAs) will be released at 7:00 AM (CT) on the day of scientific presentation at the meeting.